Join Free
SI Premium
RSS Feeds
E-mail Alerts
Portfolio
Login
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Invivyd, Inc. - Common Stock
(NQ:
IVVD
)
0.9270
+0.0227 (+2.51%)
Streaming Delayed Price
Updated: 1:59 PM EDT, Oct 11, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Invivyd, Inc. - Common Stock
< Previous
1
2
3
4
5
6
Next >
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Invivyd, Inc. f/k/a Adagio Therapeutics, Inc. (IVVD) on Behalf of Investors
February 02, 2023
From
Glancy Prongay & Murray LLP
Via
Business Wire
Bronstein, Gewirtz & Grossman, LLC Notifies Invivyd, Inc. f/k/a Adagio Therapeutics, Inc. (IVVD) Investors of Class Action and to Actively Participate
February 02, 2023
From
Bronstein, Gewirtz & Grossman, LLC
Via
Business Wire
NATIONALLY RANKED ROSEN LAW FIRM Encourages Invivyd, Inc. f/k/a Adagio Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – IVVD, ADGI
February 02, 2023
From
Rosen Law Firm
Via
Business Wire
INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Invivyd, Inc. f/k/a Adagio Therapeutics, Inc. (IVVD) on Behalf of Investors
February 01, 2023
From
Law Offices of Howard G. Smith
Via
Business Wire
Shareholder Alert: Robbins LLP Informs Investors of Class Action Against Invivyd, Inc. (IVVD) f/k/a Adagio Therapeutics, Inc.
February 01, 2023
From
Robbins LLP
Via
Business Wire
The Law Offices of Frank R. Cruz Announces Investigation of Invivyd, Inc. f/k/a Adagio Therapeutics, Inc. (IVVD) on Behalf of Investors
February 01, 2023
From
The Law Offices of Frank R. Cruz
Via
Business Wire
SHAREHOLDER ACTION REMINDER: The Schall Law Firm Encourages Investors in Invivyd, Inc. f/k/a Adagio Therapeutics, Inc. with Losses of $100,000 to Contact the Firm
February 01, 2023
From
The Schall Law Firm
Via
Business Wire
SHAREHOLDER ACTION ALERT: The Schall Law Firm Encourages Investors in Invivyd, Inc. f/k/a Adagio Therapeutics, Inc. with Losses of $100,000 to Contact the Firm
January 31, 2023
From
The Schall Law Firm
Via
Business Wire
IVVD INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Files Class Action Lawsuit Against Invivyd, Inc. f/k/a Adagio Therapeutics, Inc. and Announces Opportunity for Investors with Substantial Losses to Lead Case
January 31, 2023
From
Robbins Geller Rudman & Dowd LLP
Via
Business Wire
12 Health Care Stocks Moving In Monday's After-Market Session
January 23, 2023
Via
Benzinga
Invivyd Presented Joint Industry Rationale on Potential Expedited Development Pathways for Monoclonal Antibodies at FDA-EMA Workshop
December 19, 2022
From
Invivyd
Via
GlobeNewswire
Invivyd Appoints Jeremy Gowler as Chief Operating and Commercial Officer, Promotes Pete Schmidt, M.D., to Chief Medical Officer
December 06, 2022
From
Invivyd
Via
GlobeNewswire
Why Drive Shack Shares Jumped Over 23%; Here Are 76 Biggest Movers From Yesterday
November 22, 2022
Gainers Imago BioSciences, Inc. (NASDAQ: IMGO) shares climbed 104.5% to close at $35.59 on Monday after Merck announced it would acquire the company for $36 per share in cash.
Via
Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
November 21, 2022
Via
Benzinga
Invivyd Announces Partnership With Population Health Partners to Accelerate Clinical Development in Infectious Diseases Including COVID-19
November 17, 2022
From
Invivyd
Via
GlobeNewswire
NASDAQ:IVVD Investor Alert: Investigation over Potential Wrongdoing at Invivyd, Inc.
November 11, 2022
San Diego, CA -- (SBWIRE) -- 11/11/2022 -- Certain directors of Invivyd, Inc. are under investigation over potential breaches of fiduciary duties.
Via
SBWire
Invivyd Reports Third Quarter 2022 Financial Results and Business Highlights
November 10, 2022
From
Invivyd
Via
GlobeNewswire
Invivyd to Participate in Fireside Chat at the Jefferies London Healthcare Conference
November 09, 2022
From
Invivyd
Via
GlobeNewswire
Invivyd Announces the Appointment of Christine Lindenboom to Board of Directors
October 24, 2022
From
Invivyd
Via
GlobeNewswire
Why Snap Shares Are Trading Sharply Lower; Here Are 25 Stocks Moving Premarket
October 21, 2022
Gainers Statera Biopharma, Inc. (NASDAQ: STAB) rose 40.9% to $0.2160 in pre-market trading. Statera Biopharma recently signed a binding Memorandum of Understanding with Holobeam Technologies Inc.
Via
Benzinga
AT&T, IBM, Las Vegas Sands And Some Other Big Stocks Moving Higher On Thursday
October 20, 2022
U.S. stocks traded higher, with the Dow Jones gaining more than 100 points on Thursday. Here are some big stocks recording gains in today’s session.
Via
Benzinga
Why Super Micro Computer Shares Jumped Over 10%; Here Are 73 Biggest Movers From Yesterday
October 21, 2022
Gainers NextPlay Technologies, Inc. (NASDAQ: NXTP) shares climbed 107.3% to close at $0.4138 on Thursday after the company announced its NextFintech division received commitment for a $15 million...
Via
Benzinga
Invivyd, Inc. (NASDAQ:IVVD) Shareholder Notice: Investigation over Possible Violations of Securities Laws
October 17, 2022
San Diego, CA -- (SBWIRE) -- 10/17/2022 -- Invivyd, Inc. is under investigation over potential securities laws violations in connection with certain financial statements.
Via
SBWire
Why Ericsson Shares Are Trading Lower? Here Are 56 Stocks Moving In Thursday's Mid-Day Session
October 20, 2022
Gainers NextPlay Technologies, Inc. (NASDAQ: NXTP) shares jumped 126% to $0.4525 after the company announced its NextFintech division received commitment for a $15 million strategic investment.
Via
Benzinga
US Stock Futures Edge Lower Following Thursday's Rally; Big Bank Earnings In Focus
October 14, 2022
Pre-open movers
Via
Benzinga
Invivyd Appoints Fred Driscoll as Interim Chief Financial Officer and Announces Resource Reallocation to Maximize Integrated Discovery Platform
October 13, 2022
From
Invivyd
Via
GlobeNewswire
Invivyd to Present Multiple Posters Highlighting Clinical Data from Adintrevimab During ID Week 2022
October 12, 2022
From
Invivyd
Via
GlobeNewswire
In a New Audio Interview, Toni Loudenbeck of Traders News Source Interviews David Hering CEO, Invivyd Inc.
October 03, 2022
Via
ACCESSWIRE
Benzinga's Top Ratings Upgrades, Downgrades For September 14, 2022
September 14, 2022
Upgrades For Iris Energy Ltd (NASDAQ:IREN), Compass Point upgraded the previous rating of Neutral to Buy. The current stock performance of Iris Energy shows a 52-week-high of $17.97 and a 52-week-low...
Via
Benzinga
< Previous
1
2
3
4
5
6
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.